研究報告：2017年
前のページに戻る
1. Koike H, Nakamura T, Ikeda S, Takahashi M, Kawagashira Y, Iijima
M, Katsuno M, Sobue G: Alcoholic Myelopathy and Nutritional Deficiency. Intern
Med. 56: 105–108, 2017
2. Hasegawa S, Ito M, Fukami M, Hashimoto M, Hirayama M, Ohno K: Molecular
hydrogen alleviates motor deficits and muscle degeneration in mdx mice. Redox
Rep. 22: 26–34, 2017
3. Nakamura T, Suzuki M, Ueda M, Hirayama M, Katsuno M: Lower body
mass index is associated with orthostatic hypotension in Parkinson’s disease. J
Neurol Sci. 372: 14–18, 2017
4. Nakamura T, Sobue G: Noradrenaline and 123I-Meta-Iodobenzylguanidine
kenetics in the sympathetic nervous system. In: Clinical assessment of the
autonomic nervous system. Iwase S, hayano J, Orimo S, Eds, 2017
5. Nakamura T, Sobue G: Physiological background of the reduced
cardiac 123I-Meta-Iodobenzylguanidine uptake. In: Clinical assessment of the
autonomic nervous system. Iwase S, hayano J, Orimo S, Eds, 2017
6. Nagayama H, Maeda T, Uchiyama T, Hashimoto M, Nomoto N, Kano O,
Takahashi T, Terashi H, Hamada S, Hasegawa T, Hatano T, Takahashi T, Baba Y,
Sengoku R, Watanabe H, Inoue M, Kadowaki T, Kaneko S, Shimura H, Kubo SI; Young
Japanese Expert Group for Parkinson’s Disease and Movement Disorders:
YJ-EXPANDS: Anhedonia and its correlation with clinical aspects in Parkinson’s
disease. J Neurol Sci. 372: 403–407, 2017
7. Ishigaki S, Fujioka Y, Okada Y, Riku Y, Udagawa T, Honda D,
Yokoi S, Endo K, Ikenaka K, Takagi S, Iguchi Y, Sahara N, Takashima A, Okano H,
Yoshida M, Warita H, Aoki M, Watanabe H, Okado H, Katsuno M, Sobue G: Altered
Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes.
Cell Rep. 18: 1118–1131, 2017
8. Suzuki M, Nakamura T, Hirayama M, Ueda M, Katsuno M, Sobue G: Cardiac
parasympathetic dysfunction in the early phase of Parkinson’s disease. J
Neurol. 264: 333–340, 2017
9. Fujisawa Y, Minato T, Uemura J, Hoshiyama M, Watanabe H,
Hirayama M: Association between changes in visual evoked magnetic fields and
non-motor features in Parkinson’s disease. Nagoya J Med Sci. 79:
147–155, 2017
10. Koelman DL, Benkeser DC, Xu Y, Neo SX, Tan K, Katsuno M, Sobue
G, Natsume J, Chahin S, Mar SS, Venkatesan A, Chitnis T, Hoganson GM,
Yeshokumar AK, Barreras P, Majmudar B, Carone M, Mateen FJ: Acute disseminated
encephalomyelitis in China, Singapore and Japan: a comparison with the USA. Eur
J Neurol. 24: 391–396, 2017
11. Yoritaka, A. Abe, T. Ohtsuka, C. Maeda, T. Hirayama, M.
Watanabe, H. Saiki, H. Oyama, G. Fukae, J. Shimo, Y. Hatano, T. Kawajiri, S.
Okuma, Y. Machida, Y. Miwa, H. Suzuki, C. Kazama, A. Tomiyama, M. Kihara, T.
Hirasawa, M. Shimura, H. Hattori, N: Erratum to: A randomized double-blind
multi-center trial of hydrogen water for Parkinson’s disease: protocol and
baseline characteristics. BMC Neurol. 17: 35, 2017. (Erratum for: BMC
Neurol. 2016)
12. Koike H, Ikeda S, Takahashi M, Kawagashira Y, Iijima M, Misumi
Y, Ando Y, Ikeda SI, Katsuno M, Sobue G: Disruption of blood-nerve barriers in
hereditary transthyretin (ATTR) amyloidosis. Amyloid. 24(sup1): 89–90,
2017
13. Bagarinao E, Maesawa S, Ito Y, Usui N, Natsume J, Watanabe H,
Hoshiyama M, Wakabayashi T, Sobue G, Naganawa S, Isoda H: Detecting sub-second
changes in brain activation patterns during interictal epileptic spike using
simultaneous EEG-fMRI. Clin Neurophysiol. 129: 377–389, 2017
14. Maeda T, Shimo Y, Chiu SW, Yamaguchi T, Kashihara K, Tsuboi Y,
Nomoto M, Hattori N, Watanabe H, Saiki H; J-FIRST group: Clinical manifestations
of nonmotor symptoms in 1021 Japanese Parkinson’s disease patients from 35
medical centers. Parkinsonism Relat Disord. 38: 54–60, 2017
15. Writing Group; Edaravone (MCI-186) ALS 19 Study Group: Safety
and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis:
a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 16:
505–512, 2017
16. Nakamura T, Sobue G: Noradrenaline and 123I-Meta-Iodobenzylguanidine kenetics
in the sympathetic nervous system. In: Clinical assessment of the autonomic nervous system, Iwase S, Hayano J, Orimo S, Eds, 2017
17. Nakamura T, Sobue G: Physiological background of the reduced cardiac 123I-Meta-Iodobenzylguanidine
uptake. In: Clinical assessment of the autonomic nervous system, Iwase S, Hayano J, Orimo S, Eds, 2017
18. Banno H, Katsuno M, Suzuki K, Tanaka S, Suga N, Hashizume A,
Mano T, Araki A, Watanabe H, Fujimoto Y, Yamamoto M, Sobue G: Swallowing
markers in spinal and bulbar muscular atrophy. Ann Clin Transl Neurol.
4: 534–543, 2017
19. Nakatsuji H, Araki A, Hashizume A, Hijikata Y, Yamada S, Inagaki
T, Suzuki K, Banno H, Suga N, Okada Y, Ohyama M, Nakagawa T, Kishida K,
Funahashi T, Shimomura I, Okano H, Katsuno M, Sobue G: Correlation of insulin
resistance and motor function in spinal and bulbar muscular atrophy. J
Neurol. 264: 839–847, 2017
20. Noda S, Koike H, Maeshima S, Nakanishi H, Iijima M, Matsuo K, Kimura
S, Katsuno M, Sobue G: Transforming growth factor-β signaling is upregulated in
sporadic inclusion body myositis. Muscle Nerve. 55: 741–747, 2017
21. Parekh PK, Becker-Krail D, Sundaravelu P, Ishigaki S, Okado H,
Sobue G, Huang Y, McClung CA: Altered GluA1 (Gria1) Function and Accumbal
Synaptic Plasticity in the Clock 19 Model of Bipolar Mania. Biol Psychiatry.
27: 31721–31723, 2017
22. Koike H, Kadoya M, Kaida KI, Ikeda S, Kawagashira Y, Iijima M,
Kato D, Ogata H, Yamasaki R, Matsukawa N, Kira JI, Katsuno M, Sobue G: Paranodal
dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155
and anti-contactin-1 antibodies. J Neurol Neurosurg Psychiatry. 88:
465–473, 2017
23. Endo K, Ishigaki S, Masamizu Y, Fujioka Y, Watakabe A, Yamamori
T, Hatanaka N, Nambu A, Okado H, Katsuno M, Watanabe H, Matsuzaki M, Sobue G: Silencing
of FUS in the common marmoset (Callithrix jacchus) brain via stereotaxic injection
of an adeno-associated virus encoding shRNA. Neurosci Res. pii:
S0168–0102, 30183–9, 2017
24. Riku Y, Watanabe H, Yoshida M, Mimuro M, Iwasaki Y, Masuda M, Ishigaki
S, Katsuno M, Sobue G: Pathologic Involvement of Glutamatergic Striatal Inputs
From the Cortices in TAR DNA-Binding Protein 43kDa-Related Frontotemporal Lobar
Degeneration and Amyotrophic Lateral Sclerosis. J Neuropathol Exp Neurol.
76: 759–768, 2017
25. Yokoi S, Udagawa T, Fujioka Y, Honda D, Okado H, Watanabe H, Katsuno
M, Ishigaki S, Sobue G: 3’ UTR Length-Dependent Control of SynGAP Isoform α2
mRNA by FUS and ELAV-like Proteins Promotes Dendritic Spine Maturation and
Cognitive Function. Cell Rep. 20: 3071–3084 2017
26. Tsuboi T, Tanaka Y, Yoshida Y, Nakamura T, Shimozawa N, Katsuno
M: Highly asymmetric and subacutely progressive motor weakness with unilateral T2-weighted
high intensities along the pyramidal tract in the brainstem in
adrenomyeloneuropathy. J Neurol Sci. 381: 107–109, 2017
27. Takahashi M, Koike H, Ikeda S, Kawagashira Y, Iijima M, Hashizume
A, Katsuno M, Sobue G: Distinct pathogenesis in nonsystemic vasculitic
neuropathy and microscopic polyangiitis. Neurol Neuroimmunol Neuroinflamm.
4: e407, 2017
28. Minato T, Maeda T, Fujisawa Y, Tsuji H, Nomoto K, Ohno K, Hirayama
M: Progression of Parkinson’s disease is associated with gut dysbiosis:
Two-year follow-up study. PLoS One. 12: e0187307, 2017
29. Riku Y, Watanabe H, Mimuro M, Iwasaki Y, Ito M, Katsuno M, Sobue
G, Yoshida M: Non-motor multiple system atrophy associated with sudden death:
pathological observations of autonomic nuclei. J Neurol. 264: 2249–2257,
2017
30. Koike H, Nakamura T, Hashizume A, Nishi R, Ikeda S, Kawagashira
Y, Iijima M, Katsuno M, Sobue G: Cardiac and peripheral vasomotor autonomic
functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.
J Neurol. 264: 2293–2302, 2017
31. Senda J, Atsuta N, Watanabe H, Bagarinao E, Imai K, Yokoi D,
Riku Y, Masuda M, Nakamura R, Watanabe H, Ito M, Katsuno M, Naganawa S, Sobue
G: Structural MRI correlates of amyotrophic lateral sclerosis progression. J
Neurol Neurosurg Psychiatry. 88: 901–907, 2017
32. Kawagashira Y, Koike H, Kawabata K, Takahashi M, Ohyama K,
Hashimoto R, Iijima M, Katsuno M, Sobue G: Vasculitic Neuropathy Following
Exposure to a Glyphosate-based Herbicide. Intern Med. 56: 1431–1434,
2017
33. Hashizume A, Banno H, Katsuno M, Hijikata Y, Yamada S, Inagaki T,
Suzuki K, Sobue G: Quantitative Assessment of Swallowing Dysfunction in
Patients with Spinal and Bulbar Muscular Atrophy. Intern Med. 56:
3159–3165, 2017
34.
Tsuboi T, Watanabe H, Tanaka Y, Ohdake R, Hattori M, Kawabata K, Hara K, Ito M, Fujimoto Y, Nakatsubo D,
Maesawa S, Kajita Y,
Katsuno
M, Sobue G: Early detection of speech and
voice disorders in Parkinson’s disease patients treated with subthalamic
nucleus deep brain stimulation: a 1-year follow-up study. J Neural Transm (Vienna). 124: 1547–1556, 2017